We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
How to use a multiphase optimisation strategy (MOST) to evaluate your digital health product.
New 'innovator passport' will slash red tape so cutting-edge tech can be rolled out across the NHS quicker under the 10 Year Health Plan.
How to use a cost effectiveness analysis to evaluate your digital health product.
How to use a factorial randomised controlled trial to evaluate your digital health product.
Refreshed checklist of efficiency measures for more cost effective prescribing.
Past and current clinical trials into therapeutic and antiviral treatments for COVID-19, how to take part, and which treatments have proven to be effective.
The MHRA will help shape international rules for AI in healthcare – speeding up access to safe, effective technologies into the NHS and worldwide.
How to use a before-and-after study to evaluate your digital health product.
How to use a cost utility analysis to evaluate your digital health product.
Med Tech Regs blog, June 2025: A focus on Software and AI.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).